keyword
https://read.qxmd.com/read/38654139/randomized-investigation-of-the-mitraclip-device-in-heart-failure-design-and-rationale-of-the-reshape-hf2-trial-design
#1
JOURNAL ARTICLE
Stefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, Javed Butler, Kaneez Fatima, Monika Diek, Jutta Heinrich, Gerd Hasenfuß, Wolfgang Schillinger, Piotr Ponikowski
AIMS: The safety and effectiveness of the MitraClip device to treat functional mitral regurgitation (FMR) has been tested in previous clinical trials yielding somewhat heterogeneous results in heart failure (HF) patients. Over time, the MitraClip device system has been modified and clinical practice evolved to consider also less severely diseased HF patients with FMR for this therapeutic option. The RESHAPE-HF2 trial aims to assess the safety and effectiveness of the MitraClip device system on top of medical therapy considered optimal in the treatment of clinically significant FMR in symptomatic patients with chronic HF...
April 23, 2024: European Journal of Heart Failure
https://read.qxmd.com/read/38649992/impact-of-perioperative-low-molecular-weight-heparin-therapy-on-clinical-events-of-elderly-patients-with-prior-coronary-stents-implanted-12-months-undergoing-non-cardiac-surgery-a-randomized-placebo-controlled-trial
#2
JOURNAL ARTICLE
Bin Wang, Yanhui Su, Cong Ma, Lining Xu, Qunxia Mao, Wenjia Cheng, Qingming Lu, Ying Zhang, Rong Wang, Yan Lu, Jing He, Shihao Chen, Lei Chen, Tianzhi Li, Linggen Gao
BACKGROUND: Little is known about the safety and efficacy of discontinuing antiplatelet therapy via LMWH bridging therapy in elderly patients with coronary stents implanted for > 12 months undergoing non-cardiac surgery. This randomized trial was designed to compare the clinical benefits and risks of antiplatelet drug discontinuation via LMWH bridging therapy. METHODS: Patients were randomized 1:1 to receive subcutaneous injections of either dalteparin sodium or placebo...
April 23, 2024: BMC Medicine
https://read.qxmd.com/read/38647438/practical-training-concept-for-perfusionists-at-the-heart-and-diabetes-center-nordrhein-westfalen
#3
REVIEW
Christian Klüß, André Giesbrecht, Markus Rudloff, Vera von Dossow, Eugen Sandica, Jan Gummert
BACKGROUND: Increasing regulations and requirements of advisory bodies, in particular the Joint Federal Committee and the Medical Service of the health insurance funds, make it necessary to employ only demonstrably well-trained perfusionists. The minimum requirement for this staff is EBCP certification. Currently there is limited availability of such specialists on the German market. Therefore, the qualification of young people in this area is of central importance. The aim of this paper is to strengthen the training of perfusionists at our centre, to standardise the process and to provide the respective student with a "roadmap" to their internship...
April 22, 2024: Perfusion
https://read.qxmd.com/read/38644099/comparison-of-the-ultrasound-guided-supraclavicular-and-infraclavicular-approaches-for-subclavian-vein-cannulation-in-children-with-congenital-heart-disease
#4
JOURNAL ARTICLE
Xiaolei Gong, Nuaini Aikemu, Zhuoming Xu, Limin Zhu
OBJECTIVES: Central venous catheterization is used widely in critical pediatric patients. The authors sought to compare the success rate and safety of ultrasound-guided subclavian vein cannulation performed via infraclavicular and supraclavicular approaches. DESIGN: The authors compared the success rate of the first puncture and other information for cannulation in the children with congenital heart disease requiring central venous catheterization who were assigned randomly to the supraclavicular approach group (group A) or infraclavicular approach group (group B)...
March 24, 2024: Journal of Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/38638969/rationale-and-design-of-the-eleanor-trial-early-aortic-valve-surgery-versus-watchful-waiting-strategy-in-severe-asymptomatic-aortic-regurgitation-acronym-eleanor
#5
JOURNAL ARTICLE
Radka Kočková, Jan Vojáček, Helena Bedáňová, Petr Fila, Ivo Skalský, Daniela Žáková, Michal Klán, Barbora Míková, Karel Mědílek, Martin Tuna, Monika Fialová, Radka Dvořáková, Zuzana Hlubocká, Roman Panovský, Kryštof Slabý, Elayne Kelen de Oliveira, Filip Casselman, Martin Pěnička
BACKGROUND: The optimal treatment of patients with severe symptomatic aortic regurgitation (AR) is state-of-the-art surgery. Asymptomatic patients with advanced left ventricular (LV) dilatation and/or impaired ejection fraction should undergo surgical treatment, but there is no guidelines consensus on cut-off values for this recommendation. Multimodality imaging has brought new tools for the accurate selection of asymptomatic patients at risk of early clinical deterioration, however, prospective and randomized data are pending...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38633134/ketorolac-dosing-and-outcomes-in-neonates-following-congenital-heart-surgery-a-retrospective-analysis
#6
JOURNAL ARTICLE
Amy L Kiskaddon, Neil A Goldenberg, Trent Abel, Jamie L Fierstein, Delia Khayat, James A Quintessenza, Arabela C Stock
BACKGROUND: Pain management is essential for postoperative surgery. Given the association of opioids with adverse outcomes, interest in the use of nonopioid analgesics, such as ketorolac, has increased. Published data on use in neonates are limited. OBJECTIVES: To describe ketorolac dosing and safety and efficacy outcomes in the first 48 hours postcardiac surgery in neonates. DESIGN: We performed a single-center retrospective cohort study of neonates (ages < 28 d) who received ketorolac following cardiac surgery from November 2020 to July 2023 (inclusive)...
April 2024: Critical care explorations
https://read.qxmd.com/read/38632637/bleeding-sites-and-treatment-strategies-for-cardiac-tamponade-by-catheter-ablation-requiring-thoracotomy-risks-of-catheter-ablation-in-patients-with-left-atrial-diverticulum
#7
JOURNAL ARTICLE
Atsuyuki Mitsuishi, Yujiro Miura, Yoshinori Nomura, Takayoshi Hirota, Naoki Arima, Hiroaki Kitaoka, Hiroki Tateiwa, Yoshifumi Katsumata
BACKGROUND: There is insufficient information regarding the bleeding sites and surgical strategies of cardiac tamponade during catheter ablation for atrial fibrillation (AF). CASE PRESENTATION: Of the five patients with cardiac tamponade, three required surgical intervention and two required pericardiocentesis. In the first case of three cardiac tamponades requiring surgical intervention, considering that the peripheral route was used, the catecholamines did not reach the heart, and due to unstable vital signs, venoarterial extracorporeal membrane oxygenation (VA-ECMO) was inserted...
April 17, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38632609/the-efficacy-of-minimally-invasive-coronary-artery-bypass-grafting-mics-cabg-for-patients-with-coronary-artery-diseases-and-diabetes-a-single-center-retrospective-study
#8
JOURNAL ARTICLE
Zhao Guangxin, Chi Liqun, Liang Lin, Liu Jiaji, Ma Xiaolong, Zhang Yuxiao, Huang Qiuyue, Kong Qingyu
BACKGROUND: conventional coronary artery bypass grafting (CCABG) tends to cause severe complications in patients with comorbid Coronary Artery Diseases (CAD) and diabetes. On the other hand, the Minimally Invasive Cardiac Surgery Coronary Artery Bypass Grafting (MICS CABG) via transthoracic incision is associated with rapid recovery and reduced complications. Adding to the limited literature, this study compares CCABG and MICS CABG in terms of efficacy and safety. METHODS: Herein, 104 CCABG and MICS CABG cases (52 cases each) were included...
April 18, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38626847/characterization-of-cardiovascular-serious-adverse-events-after-bypass-or-endovascular-revascularization-for-limb-threatening-ischemia-in-the-best-cli-trial
#9
JOURNAL ARTICLE
Jeffrey J Siracuse, Matthew T Menard, Kenneth Rosenfield, Michael S Conte, Richard Powell, Naomi Hamburg, Gheorghe Doros, Michael B Strong, Alik Farber
OBJECTIVES: Cardiovascular complications after revascularization to treat chronic limb threatening ischemia (CLTI) are a major concern that guides treatment. Our goal was to assess periprocedural cardiac and vascular serious adverse events (SAE) in the Best Endovascular versus Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial. METHODS: BEST-CLI was a prospective randomized trial comparing surgical (OPEN) and endovascular (ENDO) revascularization for patients with CLTI...
April 14, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38624192/inspiratory-muscle-training-in-phase-1-and-2-postoperative-cardiac-rehabilitation-following-coronary-artery-bypass-graft-surgery-systematic-review-with-meta-analysis
#10
JOURNAL ARTICLE
Clênia Oliveira Araújo, Carla Cristina Araújo Alves, Francisco R A Santos, Lawrence P Cahalin, Graziella França Bernardelli Cipriano, Gerson Cipriano
OBJECTIVE: This study aimed to determine the effects of inspiratory muscle training (IMT) on exercise capacity, respiratory muscle strength, length of hospital stay (LOS), and quality of life (QOL) following coronary artery bypass graft surgery. METHODS: The search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the Cochrane Handbook and included the databases MEDLINE, EMBASE, CINAHL, Scopus, and CENTRAL...
April 16, 2024: Physical Therapy
https://read.qxmd.com/read/38621711/feasibility-and-safety-of-bridging-antiplatelet-therapy-with-cangrelor-in-neuro-oncology-a-preliminary-experience
#11
JOURNAL ARTICLE
Giacomo Bertolini, Laura Belli, Stefania Mazza, Pietro Tito Ugolotti, Iacopo Tadonio, Patrizia Ceccarelli, Sandra Rossi, Salvatore Ippolito
Antiplatelet therapy is mandatory for prevention of thrombotic events in patients with a recent history of acute coronary syndromes and/or percutaneous coronary interventions. However, if an urgent surgery is required during antiplatelet therapy, a compromise between the ischemic/thrombotic and hemorrhagic risk has to be reached. Different bridging schemes are reported in the literature, but there is no clear consensus on the optimal treatment strategy in terms of efficacy and safety. Although some indications about the perioperative management of antiplatelet therapy regarding specific surgical specializations are available, balancing the thrombotic and hemorrhagic risk on an individual basis, no evidence referring to neurosurgical or neuro-oncologic procedures is reported...
April 15, 2024: Journal of Neurological Surgery. Part A, Central European Neurosurgery
https://read.qxmd.com/read/38607606/safety-and-outcomes-of-surgical-treatment-of-atrial-fibrillation-in-emergency-surgery-cases
#12
JOURNAL ARTICLE
Shun-Ichiro Sakamoto, Tomohiro Murata, Motohiro Maeda, Atsushi Hiromoto, Takako Yamaguchi, Kenji Suzuki, Yosuke Ishii
BACKGROUND: Recent developments in surgical devices, including left atrial appendage closure, have enabled surgeons to perform aggressive operations for atrial fibrillation (AF). However, the outcomes of AF surgery in emergent cases have not been extensively studied. OBJECTIVE AND METHODS: The present study aimed to investigate the effectiveness of AF surgery in emergency surgery cases associated with cardiovascular events. We enrolled 18 patients who underwent various types of AF surgery due to emergencies, including acute aortic dissection (n = 6), acute myocardial infarction (n = 5), bleeding due to perforation from radiofrequency catheter ablation (n = 4), acute mitral regurgitation (n = 2), and cardiac tumor (n = 1)...
April 12, 2024: General Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38607223/the-impact-of-valve-surgery-on-the-safety-and-cardiac-function-of-patients-with-valvular-heart-disease-complicated-by-pulmonary-arterial-hypertension
#13
JOURNAL ARTICLE
Shiliang Li, Zijun Chen, Kunsheng Li, Ziyue Zhang, Yan Zhou
OBJECTIVE: This study evaluates the effects of valve surgery on safety and cardiac function in patients with valvular heart disease complicated by pulmonary arterial hypertension (PAH), focusing on postoperative outcomes influenced by age, heart function grade, and PAH severity. METHODS: A retrospective analysis was conducted on 307 valve surgery patients from April 2017 to April 2022. The cohort had a mean age of 57.6 years, with 56.9% males, and was stratified by NYHA functional class II-IV...
April 12, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38604885/thoracoscopic-left-atrial-appendage-occlusion-with-the-atriclip-pro2-an%C3%A2-experience-of-144-patients
#14
JOURNAL ARTICLE
Edward Wang, Paul Sadleir, Vijay Sourinathan, Rukshen Weerasooriya, David Playford, Pragnesh Joshi
AIM: To report the clinical outcomes of thoracoscopic left atrial appendage occlusion (LAAO) with the AtriClip PRO2 device (Atricure Inc, Mason, OH, USA). Stroke risk reduction with LAAO in patients with atrial fibrillation is now well-established. Many surgical and percutaneous techniques have been used, with varying rates of success. The percutaneous devices have had issues with procedural complications and peridevice flow. Thoracoscopic AtriClip offers an epicardial linear closure of the appendage at its ostium...
April 10, 2024: Heart, Lung & Circulation
https://read.qxmd.com/read/38602077/safety-timing-and-outcomes-of-early-post-operative-cardiac-catheterisation-following-congenital-heart-surgery
#15
JOURNAL ARTICLE
Karoline Krzywda, Jeremy T Affolter, Darcie M Al-Hassan, William J Gibson, Ryan A Romans, Hung-Wen Yeh, Kelly S Tieves
OBJECTIVE: The safety of early post-operative cardiac catheterisation has been described following congenital heart surgery. Optimal timing of early post-operative cardiac catheterisation remains uncertain. The aim of this study was to describe the safety of early post-operative cardiac catheterisation and its impact on cardiac ICU and hospital length of stay, duration of mechanical ventilation, and extracorporeal support. METHODS: This single-centre retrospective cohort study compared clinical and outcome variables between "early" early post-operative cardiac catheterisation (less than 72 hours after surgery) and "late" early post-operative cardiac catheterisation (greater than 72 hours after surgery) groups using Chi-squared, Student's t, and log-rank test (or appropriate nonparametric test)...
April 11, 2024: Cardiology in the Young
https://read.qxmd.com/read/38601251/does-tranexamic-acid-reduce-the-need-for-hypotensive-anesthesia-within-orthognathic-surgery-a-retrospective-study
#16
JOURNAL ARTICLE
Chad W Dammling, Timothy M Weber, Kenneth J Taylor, Brian E Kinard
BACKGROUND: Tranexamic acid (TXA) is utilized frequently in orthognathic surgery to limit blood loss and improve surgical field visualization. This antifibrinolytic has been proven effective with use of concomitant hypotensive anesthesia. Despite proven efficacy, there is a recent push to avoid perioperative hypotensive anesthesia due to risks of organ hypoperfusion, cardiac ischemia and postoperative nausea. AIMS: The aim is to study the efficacy and safety of utilizing TXA without controlled hypotensive anesthesia...
April 2024: Journal of Maxillofacial and Oral Surgery
https://read.qxmd.com/read/38598445/hybrid-noncovered-open-stents-in-repair-of-debakey-type-1-acute-aortic-dissections
#17
JOURNAL ARTICLE
Suvitesh Luthra, Szabolcs Miskolczi, Theodore Velissaris, Ravi J De Silva, Maximillian Luehr, Jörg Kempfert, Michael C Moon
INTRODUCTION: The indications for use, evidence base and experience with the novel noncovered open hybrid surgical stents for acute type A aortic dissection repair for concurrent stabilization of the "downstream" aorta remains limited. We review the evidence base and the development of these stents. METHODS: Data were collected from Pubmed/Medline literature search to develop and review the evidence base for safety and efficacy of non-covered surgical stents. Existing guidelines for use and developments were reviewed...
April 10, 2024: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/38592256/quality-improvement-in-anesthetic-management-of-patients-with-left-ventricular-assist-device-support-presenting-for-non-cardiac-surgery-a-single-center-experience
#18
JOURNAL ARTICLE
Dana D Yahav-Shafir, Ascher Jekutiel Gérard Schmelczer, Jonathan Frogel, Ilya Matskovsky, Amir Zabida, Jonathan Eisenberger, Jeffrey A Morgan
With the growing number of left ventricular assist device (LVAD) recipients requiring non-cardiac surgery and the limited availability of cardiac anesthesiologists, our study reviewed non-cardiac surgeries in HeartMate III patients with LVAD at our institution. We focused on anesthesiologist roles, detailing patient characteristics, anesthetic management, and outcomes and identifying improvement opportunities in this specialized care setting. A retrospective chart review was conducted of all patients with LVAD who underwent non-cardiac surgery at our institution between 2017 and 2022...
February 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38590997/atrial-fibrillation-symptom-reduction-and-improved-quality-of-life-following-the-hybrid-convergent-procedure-a-converge-trial-subanalysis
#19
JOURNAL ARTICLE
Jaswinder Gill, Karl J Crossen, Christopher Blauth, Faraz Kerendi, Saumil R Oza, Anthony R Magnano, Mark A Mostovych, Michael E Halkos, David Tschopp, Jose Osorio, Paul Tabereaux, William Boedefeld, Kenneth Civello, Syed Ahsan, John Yap, Sreedhar Billakanty, Steve Duff, Otto Costantini, Eric Espinal, Andy Kiser, Christian Shults, David Pederson, James Garrison, David M Gilligan, Michael G Link, Marcin Kowalski, Christopher Stees, Jason S Sperling, Israel Jacobowitz, Felix Yang, Yisachar J Greenberg, David B De Lurgio
BACKGROUND: CONVERGE was a prospective, multicenter, randomized controlled trial that evaluated the safety of Hybrid Atrial Fibrillation Convergent (HC) and compared its effectiveness to endocardial catheter ablation (CA) for the treatment of persistent atrial fibrillation (PersAF) and longstanding PersAF (LSPAF). In 2020, we reported that CONVERGE met its primary safety and effectiveness endpoints. The primary objective of the present study is to report CONVERGE trial results for quality of life (QOL) and Class I/III anti-arrhythmic drug (AAD) utilization following HC...
March 29, 2024: Annals of Cardiothoracic Surgery
https://read.qxmd.com/read/38590193/-retrospective-study-of-bronchoscopic-intervention-therapy-for-bronchopleural-fistula-induced-by-pulmonary-surgery
#20
JOURNAL ARTICLE
Xiaosen Huo, Yuan Li, Yanyan Dong, Lingjie Bian, Peng An, Hang Zou, Lei Li, Hongwu Wang
BACKGROUND: As a new technique developed in recent years, bronchoscopic intervention therapy has the advantages of minimal invasion, high safety and repeatability. The aim of this study is to investigate the clinical characteristics of bronchopleural fistula (BPF) induced by surgeries for lung malignancies or benign diseases and the effect of bronchoscopic intervention therapy for BPF, so as to provide support for prevention and treatment of BPF. METHODS: Data 64 patients with BPF who were treated by bronchoscopic intervention in Respiratory Disease Center of Dongzhimen Hospital, Beijing University of Chinese Medicine from June 2020 to September 2023 were collected...
March 20, 2024: Zhongguo Fei Ai za Zhi, Chinese Journal of Lung Cancer
keyword
keyword
21057
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.